Publicaciones (44) Publicaciones de LUIS GARCÍA GARCÍA

2023

  1. A Single High Dose of Flufenamic Acid in Rats does not Reduce the Damage Associated with the Rat Lithium-Pilocarpine Model of Status Epilepticus but Leads to Deleterious Outcomes

    Journal of integrative neuroscience, Vol. 22, Núm. 3, pp. 75

  2. The vasodilator naftidrofuryl attenuates short-term brain glucose hypometabolism in the lithium-pilocarpine rat model of status epilepticus without providing neuroprotection

    European Journal of Pharmacology, Vol. 939

  3. Tolerancia y procesos de adaptación

    Fundamentos de farmacología básica y clínica (Editorial Médica Panamericana), pp. 355-366

2022

  1. Experimental models in the study of epileptogenesis

    ANALES RANM, Vol. 139, Núm. 139(02), pp. 140-149

  2. Functionalization of Morin-Loaded PLGA Nanoparticles with Phenylalanine Dipeptide Targeting the Brain

    Pharmaceutics, Vol. 14, Núm. 11

  3. Micro-and Nano-Systems Developed for Tolcapone in Parkinson’s Disease

    Pharmaceutics, Vol. 14, Núm. 5

  4. PET Imaging and Neurohistochemistry Reveal that Curcumin Attenuates Brain Hypometabolism and Hippocampal Damage Induced by Status Epilepticus in Rats

    Planta Medica, Vol. 89, Núm. 4, pp. 364-376

  5. Significance of Brain Glucose Hypometabolism, Altered Insulin Signal Transduction, and Insulin Resistance in Several Neurological Diseases

    Frontiers in Endocrinology, Vol. 13

2021

  1. 99mTc-HMPAO SPECT imaging reveals brain hypoperfusion during status epilepticus

    Metabolic Brain Disease, Vol. 36, Núm. 8, pp. 2597-2602

2019

  1. Cannabidiol Enhances the Passage of Lipid Nanocapsules across the Blood-Brain Barrier Both in Vitro and in Vivo

    Molecular Pharmaceutics, Vol. 16, Núm. 5, pp. 1999-2010

  2. PET Neuroimaging Reveals Serotonergic and Metabolic Dysfunctions in the Hippocampal Electrical Kindling Model of Epileptogenesis

    Neuroscience, Vol. 409, pp. 101-110

2018

  1. Metyrapone prevents acute glucose hypermetabolism and short-term brain damage induced by intrahippocampal administration of 4-aminopyridine in rats

    Neurochemistry International, Vol. 113, pp. 92-106

2017

  1. Anxiogenic-like effects of fluoxetine render adult male rats vulnerable to the effects of a novel stress

    Pharmacology Biochemistry and Behavior, Vol. 153, pp. 32-44

  2. Efficacy of ropinirole-loaded PLGA microspheres for the reversion of rotenone- induced parkinsonism

    Current Pharmaceutical Design, Vol. 23, Núm. 23, pp. 3423-3431

  3. Insulin regulates astrocytic glucose handling through cooperation with IGF-I

    Diabetes, Vol. 66, Núm. 1, pp. 64-74

  4. Metyrapone prevents brain damage induced by status epilepticus in the rat lithium-pilocarpine model

    Neuropharmacology, Vol. 123, pp. 261-273

  5. Nanotechnology-based drug delivery of ropinirole for parkinson’s disease

    Drug Delivery, Vol. 24, Núm. 1, pp. 1112-1123

  6. Subacute fluoxetine reduces signs of hippocampal damage induced by a single convulsant dose of 4-aminopyridine in rats

    CNS and Neurological Disorders - Drug Targets, Vol. 16, Núm. 6, pp. 694-704

  7. Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis

    International Journal of Nanomedicine, Vol. 12, pp. 1959-1968

2016

  1. Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3

    Neuroscience, Vol. 339, pp. 191-209